Heart Disease Clinical Trials in Massachusetts

Showing 401-420 of 451 trials

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

NCT00984802

This study is conducted to assess the safety of CMX-2043 solution for intravenous (IV) injection, and to evaluate efficacy on the basis of the changes seen in the cardiac biomarkers and continuous electrocardiography (ECG) monitoring. Additionally, correlation of the levels/changes in the biomarkers and the pharmacokinetic evaluations of the drug will be explored.

Stable Coronary Artery DiseasePercutaneous Coronary Intervention

Ischemix, LLC142 participantsStarted Feb 2010

Worcester, Massachusetts, United States • Durham, North Carolina, United States • Chennai, India +2 more locations

COMPLETEDPhase 414 miles

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

NCT00673075

This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patients who have coronary artery disease.

HypertensionCoronary Artery Disease

Forest Laboratories39 participantsStarted May 2008

Birmingham, Alabama, United States • Peoria, Arizona, United States • Buena Park, California, United States +31 more locations

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Heart Disease Trials in Other Cities

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Peripheral Venous Oxygen Saturation and Biomarkers to Estimate Cardiac Output and Filling Pressures in Heart Failure

Mind-body Interventions in Cardiac Patients

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

Other Conditions in Massachusetts